Generic Analgesic Labeling Foreign Ingredient Reference Required – FTC
This article was originally published in The Tan Sheet
Executive Summary
Private label OTC analgesic manufacturers who use imported active ingredients will be required to disclose such details when an origin statement is included on product labeling, according to five 1Federal Trade Commission proposed settlements announced Nov. 6
You may also be interested in...
FTC “Made in U.S.A.”
Commission approves five final consent orders Feb. 22 requiring private label OTC analgesic manufacturers who use imported active ingredients to disclose such details when an origin statement is included on product labeling (1"The Tan Sheet" Nov. 12, 2001, p. 3). FTC clears consent orders with Perrigo, Leiner, Pharmaceutical Formulations, Inc., LNK International, A&S Pharmaceutical in separate 5-0 votes...
FTC “Made in U.S.A.”
Commission approves five final consent orders Feb. 22 requiring private label OTC analgesic manufacturers who use imported active ingredients to disclose such details when an origin statement is included on product labeling (1"The Tan Sheet" Nov. 12, 2001, p. 3). FTC clears consent orders with Perrigo, Leiner, Pharmaceutical Formulations, Inc., LNK International, A&S Pharmaceutical in separate 5-0 votes...
FTC “Made in U.S.A.”
Commission approves five final consent orders Feb. 22 requiring private label OTC analgesic manufacturers who use imported active ingredients to disclose such details when an origin statement is included on product labeling (1"The Tan Sheet" Nov. 12, 2001, p. 3). FTC clears consent orders with Perrigo, Leiner, Pharmaceutical Formulations, Inc., LNK International, A&S Pharmaceutical in separate 5-0 votes...